loadpatents
Patent applications and USPTO patent grants for Brandt; Gary E.L..The latest application filed is for "jak kinase inhibitor compounds for treatment of respiratory disease".
Patent | Date |
---|---|
Jak Kinase Inhibitor Compounds For Treatment Of Respiratory Disease App 20220306624 - Fatheree; Paul R. ;   et al. | 2022-09-29 |
JAK inhibitors containing a 4-membered heterocyclic amide Grant 11,453,668 - Fatheree , et al. September 27, 2 | 2022-09-27 |
Fused Imidazo-piperidine Jak Inhibitors App 20220289737 - Fatheree; Paul R. ;   et al. | 2022-09-15 |
Pyrimidine compound as JAK kinase inhibitor Grant 11,420,965 - Kozak , et al. August 23, 2 | 2022-08-23 |
JAK kinase inhibitor compounds for treatment of respiratory disease Grant 11,299,492 - Fatheree , et al. April 12, 2 | 2022-04-12 |
Fused imidazo-piperidine JAK inhibitors Grant 11,254,669 - Fatheree , et al. February 22, 2 | 2022-02-22 |
Jak Inhibitors Containing A 4-membered Heterocyclic Amide App 20210269436 - FATHEREE; PAUL R. ;   et al. | 2021-09-02 |
Pyrimidine Compound As Jak Kinase Inhibitor App 20210214349 - Kozak; Jennifer ;   et al. | 2021-07-15 |
Jak Kinase Inhibitor Compounds For Treatment Of Respiratory Disease App 20210130351 - Fatheree; Paul R. ;   et al. | 2021-05-06 |
Pyrimidine compound as JAK kinase inhibitor Grant 10,988,470 - Kozak , et al. April 27, 2 | 2021-04-27 |
JAK inhibitors containing a 4-membered heterocyclic amide Grant 10,954,237 - Fatheree , et al. March 23, 2 | 2021-03-23 |
JAK kinase inhibitor compounds for treatment of respiratory disease Grant 10,913,740 - Fatheree , et al. February 9, 2 | 2021-02-09 |
Pyrimidine Compound As Jak Kinase Inhibitor App 20200369660 - KOZAK; JENNIFER ;   et al. | 2020-11-26 |
Jak Inhibitors Containing A 4-membered Heterocyclic Amide App 20200216447 - FATHEREE; PAUL R. ;   et al. | 2020-07-09 |
Fused Imidazo-piperidine Jak Inhibitors App 20200181141 - FATHEREE; PAUL R. ;   et al. | 2020-06-11 |
JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease App 20200087303 - Fatheree; Paul R. ;   et al. | 2020-03-19 |
Pyrimidine compound as JAK kinase inhibitor Grant 10,562,894 - Kozak , et al. Feb | 2020-02-18 |
JAK inhibitors containing a 4-membered heterocyclic amide Grant 10,550,118 - Fatheree , et al. Fe | 2020-02-04 |
JAK kinase inhibitor compounds for treatment of respiratory disease Grant 10,526,330 - Fatheree , et al. J | 2020-01-07 |
Fused imidazo-piperidine JAK inhibitors Grant 10,519,153 - Fatheree , et al. Dec | 2019-12-31 |
Jak Inhibitors Containing A 4-membered Heterocyclic Amide App 20190337945 - FATHEREE; Paul R. ;   et al. | 2019-11-07 |
JAK inhibitors containing a 4-membered heterocyclic amide Grant 10,392,386 - Fatheree , et al. A | 2019-08-27 |
Pyrimidine Compound As Jak Kinase Inhibitor App 20190241555 - KOZAK; JENNIFER ;   et al. | 2019-08-08 |
Pyrimidine compound as JAK kinase inhibitor Grant 10,308,646 - Kozak , et al. | 2019-06-04 |
Fused Imidazo-piperidine Jak Inhibitors App 20190127371 - FATHEREE; PAUL R. ;   et al. | 2019-05-02 |
Pyrimidine Compound As Jak Kinase Inhibitor App 20190127364 - KOZAK; JENNIFER ;   et al. | 2019-05-02 |
Jak Inhibitors Containing A 4-membered Heterocyclic Amide App 20190119275 - FATHEREE; PAUL R. ;   et al. | 2019-04-25 |
JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease App 20190106420 - Fatheree; Paul R. ;   et al. | 2019-04-11 |
Fused imidazo-piperidine JAK inhibitors Grant 10,208,040 - Fatheree , et al. Feb | 2019-02-19 |
JAK inhibitors containing a 4-membered heterocyclic amide Grant 10,196,393 - Fatheree , et al. Fe | 2019-02-05 |
Jak Inhibitors Containing A 4-membered Heterocyclic Amide App 20180258087 - FATHEREE; PAUL R. ;   et al. | 2018-09-13 |
Fused Imidazo-piperidine Jak Inhibitors App 20180258088 - FATHEREE; PAUL R. ;   et al. | 2018-09-13 |
Substituted naphthyridines as JAK kinase inhibitors Grant 9,725,470 - Hudson , et al. August 8, 2 | 2017-08-08 |
Naphthyridine Compounds As Jak Kinase Inhibitors App 20160347772 - Hudson; Ryan ;   et al. | 2016-12-01 |
1,2,4-triazol-5-ones and analogs exhibiting anti-cancer and anti-proliferative activities Grant 9,193,719 - Flynn , et al. November 24, 2 | 2015-11-24 |
1,2,4-triazol-5-ones And Analogs Exhibiting Anti-cancer And Anti-proliferative Activities App 20140296252 - Flynn; Daniel L. ;   et al. | 2014-10-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.